AsianInvesterAsianInvesterAsianInvester

Next-gen sequencing: Why gene research delivers returns to investors

Federated Hermes
Rapid developments in genetic sequencing by the world’s top researchers has the potential to create healthier lives and revolutionise medical treatment. Investing in sustainable technology is central to Hermes Impact Opportunities Fund’s investment strategy.
Next-gen sequencing: Why gene research delivers returns to investors

Advanced genetic sequencing may be capable of fulfilling one of the greatest promises in medical treatment. It aims to decipher the human genome – our body’s complete set of genetic information – thereby supporting breakthroughs in medical research and treatment. As such, companies leading in this field are aligned with the Hermes Impact Opportunities Fund’s Health and Wellbeing investment theme.

Sign in to read on!
Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to AsianInvestor

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
If you are a senior professional at a large institutional asset owner, such as a sovereign wealth fund or pension fund, please contact [email protected] for further assistance.

Questions?
See here for more information on licences and prices, or contact [email protected]
¬ Haymarket Media Limited. All rights reserved.